Castle Biosciences

Castle Biosciences Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Castle Biosciences key operating metrics including Patents Issued , environmental, and social and governance score (ESG).

Patents Issued

300.0%

FY, 2021

Patents (US)

140.0%

Q1, 2022

Patent Applications

116.7%

FY, 2021

Operating Metrics

Metrics	FY, 2019	FY, 2020	FY, 2021
Patents Issued	16	18	72
Patents (US)	5	5	12
Patent Applications	9	18	39
Patent Applications (US)	3	6	10
Trademarks (US)	7	8	13
GEP Test Reports (DecisionDx-Melanoma)	15.5K	16.2K	20.3K
Facility Space Leased, sq. ft.	49.4K	57.9K	61.5K
Test Reports	17.1K	18.2K	28.1K
GEP Test Reports (DecisionDx-UM)	1.5K	1.4K	1.6K
Clinical Samples Processed to Date	60K	70K
GEP Test Reports (DecisionDx-SCC)		485	3.5K
GEP Test Reports (DecisionDx DiffDx-Melanoma)		73
GEP Test Reports (Dermatologic)			26.5K
GEP Test Reports (CDO)			2.7K

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub